Tumour-infiltrating lymphocytes (TIL)

Webinar

Enhancing T Cell Function for Cancer immunotherapy...

Mar. 20, 2023

Read more about the webinar - Enhancing T Cell Function for Cancer immunotherapy With CRISPR

Clinical Update: News on Two Cancer Gene Editing...

Mar. 24, 2022

This week's update features Iovance Biotherapeutics' new cancer immunotherapy candidate IOV-4001 that was recently cleared for clinical trial...

PD-1 Targeted Cancer Immunotherapy Meets CRISPR

Feb. 28, 2022

At a Danish hospital, researchers have integrated CRISPR gene editing into a clinical scale workflow for immunotherapy. Gene editing releases a brake...